Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Arhaus, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-60.5% vs price
Base Case (Median)
-35.3% vs price
Bull Case (75th pct.)
-12.6% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $9.44 | -7.9% | Medium (25%) |
| Growth Trajectory DCF | $16.85 | 64.6% | Medium (20%) |
| Graham Number | $5.77 | -43.7% | Medium (30%) |
| EV/EBITDA | $7.50 | -26.8% | Medium (20%) |
| EV/FCF | $3.46 | -66.2% | Medium (20%) |
| Earnings Power Value | $3.40 | -66.8% | Medium (50%) |
Based on 6 out of 7 methods, ARHS appears overvalued at the current price of $10.24. The base case fair value of $6.63 implies 35.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.